Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 20 studies | 34% ± 12% | |
fibroblast | 15 studies | 24% ± 6% | |
pericyte | 13 studies | 22% ± 5% | |
smooth muscle cell | 10 studies | 22% ± 6% | |
natural killer cell | 9 studies | 22% ± 8% | |
endothelial cell | 9 studies | 28% ± 9% | |
B cell | 6 studies | 24% ± 8% | |
myofibroblast cell | 6 studies | 21% ± 4% | |
epithelial cell | 5 studies | 41% ± 15% | |
basal cell | 5 studies | 31% ± 10% | |
connective tissue cell | 5 studies | 27% ± 7% | |
conventional dendritic cell | 4 studies | 25% ± 16% | |
abnormal cell | 4 studies | 22% ± 5% | |
ciliated cell | 4 studies | 30% ± 7% | |
neuron | 4 studies | 26% ± 6% | |
astrocyte | 4 studies | 25% ± 4% | |
oligodendrocyte | 4 studies | 17% ± 1% | |
T cell | 3 studies | 22% ± 4% | |
mast cell | 3 studies | 17% ± 1% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 24% ± 6% | |
CD4-positive, alpha-beta T cell | 3 studies | 28% ± 9% | |
mature NK T cell | 3 studies | 27% ± 5% | |
kidney loop of Henle epithelial cell | 3 studies | 24% ± 6% | |
GABAergic neuron | 3 studies | 39% ± 10% | |
glutamatergic neuron | 3 studies | 32% ± 14% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 3% | |
dendritic cell | 3 studies | 34% ± 23% | |
goblet cell | 3 studies | 18% ± 4% | |
intestinal crypt stem cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1630.02 | 1445 / 1445 | 100% | 15.75 | 183 / 183 |
ovary | 100% | 2120.09 | 180 / 180 | 100% | 30.56 | 430 / 430 |
stomach | 100% | 1232.99 | 359 / 359 | 100% | 21.17 | 286 / 286 |
thymus | 100% | 1742.65 | 653 / 653 | 100% | 26.51 | 605 / 605 |
uterus | 100% | 1942.55 | 170 / 170 | 100% | 29.77 | 459 / 459 |
brain | 100% | 932.10 | 2637 / 2642 | 100% | 19.36 | 705 / 705 |
lung | 100% | 1281.16 | 576 / 578 | 100% | 18.20 | 1155 / 1155 |
bladder | 100% | 1942.71 | 21 / 21 | 100% | 24.37 | 502 / 504 |
skin | 100% | 1950.87 | 1809 / 1809 | 100% | 18.73 | 470 / 472 |
kidney | 100% | 1736.55 | 89 / 89 | 100% | 16.25 | 897 / 901 |
intestine | 100% | 1684.25 | 966 / 966 | 99% | 22.74 | 524 / 527 |
prostate | 100% | 1874.63 | 245 / 245 | 99% | 18.32 | 499 / 502 |
breast | 100% | 1576.76 | 459 / 459 | 99% | 20.09 | 1111 / 1118 |
adrenal gland | 100% | 1116.62 | 258 / 258 | 99% | 13.01 | 227 / 230 |
pancreas | 98% | 608.90 | 320 / 328 | 99% | 19.18 | 177 / 178 |
liver | 98% | 623.21 | 222 / 226 | 94% | 10.08 | 382 / 406 |
adipose | 100% | 1479.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1976.00 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 20.00 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.04 | 29 / 29 |
spleen | 100% | 1237.43 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 19.71 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.08 | 1 / 1 |
heart | 100% | 1196.26 | 860 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 657.36 | 790 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 617.63 | 832 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0045596 | Biological process | negative regulation of cell differentiation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0070316 | Biological process | regulation of G0 to G1 transition |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_1902459 | Biological process | positive regulation of stem cell population maintenance |
GO_0030071 | Biological process | regulation of mitotic metaphase/anaphase transition |
GO_2000781 | Biological process | positive regulation of double-strand break repair |
GO_0006338 | Biological process | chromatin remodeling |
GO_2000819 | Biological process | regulation of nucleotide-excision repair |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0140288 | Cellular component | GBAF complex |
GO_0016514 | Cellular component | SWI/SNF complex |
GO_0000785 | Cellular component | chromatin |
Gene name | BCL7C |
Protein name | B-cell CLL/lymphoma 7 protein family member C BAF chromatin remodeling complex subunit BCL7C |
Synonyms | |
Description | FUNCTION: May play an anti-apoptotic role. . |
Accessions | ENST00000574418.5 ENST00000215115.5 [Q8WUZ0-1] ENST00000572628.5 Q8WUZ0 I3L1Q2 I3L4D5 ENST00000380317.8 [Q8WUZ0-2] |